Close

COVID-19 UPDATE

We are closely monitoring our supply chain of EPIDIOLEX® (cannabidiol) and, at this time, do not foresee any supply interruptions in the United States.

At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees. Our hearts and thoughts go out to the people who have been affected. We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent.